Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Cell Culture

Jan Lichtenberg's Biography

Jan Lichtenberg, CEO & Co-Founder, InSphero AG

Jan Lichtenberg, Ph.D., is Co-Founder and CEO of Swiss- and US-based InSphero Inc., the pioneer of industrial-grade, 3D-cell-based assay solutions and scaffold-free 3D organ-on-a-chip technology. Through partnerships, InSphero supports pharmaceutical and biotechnology researchers in successful decision-making by accurately rebuilding the human physiology in vitro. The company specializes in liver toxicology, metabolic diseases (e.g., T1 & T2 diabetes and NAFLD & NASH liver disease), and oncology (with a focus on immuno-oncology and PDX models). The scalable Akura™ technology underlying the company’s 3D InSight™ Discovery and Safety Platforms includes 96 and 384-well plate formats and the Akura™ Flow organ-on-a-chip system to drive efficient innovation throughout all phases of drug development. Jan co-founded InSphero in 2009 and expanded the business to encompass all top 15 global pharmaceutical companies. Prior to InSphero, Jan had VP R&D and Product Management positions at Hocoma AG (medical robotics) and Uwatec (microelectronics). He holds a Ph.D. from the University of Neuchâtel and managed a research group at the Swiss Federal Institute of Technology (ETH), Zurich.

Jan Lichtenberg Image

Better in vitro Biology: 3D Microtissues for Drug De-risking

Wednesday, 23 January 2013 at 16:15

Add to Calendar ▼2013-01-23 16:15:002013-01-23 17:15:00Europe/LondonBetter in vitro Biology: 3D Microtissues for Drug

Mimicking the 3-dimensional and cell composition of a tissue in vitro is essential to maintain cell-specific functionality to better de-risk compounds and biologicals. Here we present the cellular self-assembly approach to create a tissue-like environment with applications in efficacy and safety testing.

Add to Calendar ▼2013-01-22 00:00:002013-01-23 00:00:00Europe/LondonCell